Patients in the UAE now have access to the oral version of the Wegovy weight-loss medication, marking a significant milestone as the country becomes the first market outside the United States to offer this treatment. Developed by Novo Nordisk, this once-daily pill provides a needle-free alternative for adults struggling with obesity or weight-related health issues. Priced starting at Dh779, the medication is designed to complement a balanced diet and regular exercise, and it is available in various dosages tailored to individual patient requirements.

Healthcare providers have already noted a surge in interest, with platforms like DarDoc reporting an overwhelming demand since the launch. Currently, prescriptions are being issued at a rapid pace—roughly every 17 minutes—reflecting the UAE's robust healthcare landscape and the growing need for medical weight-management solutions. While this arrival offers a promising new tool for chronic weight control, medical experts strongly urge individuals to consult with a healthcare professional before beginning treatment to ensure it is the right path for their specific health needs.